Recommendations for identifying neuromyelitis optica spectrum disorders in the community and using immunosuppressive therapy to help prevent acute attacks.
EP. 1: Raising Awareness About NMOSDSeptember 21st 2021
Mayo Clinic’s Brian G. Weinshenker, MD, compares multiple sclerosis with neuromyelitis optica spectrum disorders (NMOSD) and explains why community neurologists need to receive more education on NMOSD risk factors and symptoms.
EP. 2: Receiving a Diagnosis of NMOSDSeptember 21st 2021
Doug and Kim, patients with neuromyelitis optica spectrum disorders, describe the types of symptoms that prompted each of them to seek an evaluation by a neurologist for an eventual diagnosis of a neuromyelitis optica spectrum disorder.
EP. 4: Identifying and Managing NMOSDSeptember 28th 2021
Types of testing that can help neurologists distinguish between acute attacks of neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis, as well as therapies that can be used to help manage patients with NMOSD.
EP. 7: Navigating NMOSD Infusion-Based TreatmentOctober 12th 2021
Kim, a patient with neuromyelitis optica, describes what it has been like receiving rituximab infusions as preventive therapy, and shares advice for others who are about to embark on a similar treatment journey.
EP. 9: NMOSD Research ProgramsOctober 19th 2021
Jacinta M. Behne, MA, of the Guthy-Jackson Charitable Foundation, reacts to the types of research programs the organization has been involved in, regarding better treatments for patients with neuromyelitis optica spectrum disorders.